首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素对肺原性心脏病心力衰竭的临床疗效
引用本文:张作清,刘宝珍.低分子肝素对肺原性心脏病心力衰竭的临床疗效[J].黑龙江医学,2007,31(7):502-503.
作者姓名:张作清  刘宝珍
作者单位:北京市石景山医院,北京,100043
摘    要:目的观察低分子肝素治疗肺原性心脏病(肺心病)心力衰竭的临床疗效。方法对两组患者分别应用常规疗法和加用低分子肝素治疗7d,观察两组疗效及不良反应。结果观察组临床疗效明显优于对照组且无明显不良反应。结论对于肺心病心力衰竭患者,在常规治疗的基础上加用低分子肝素可降低患者的血液黏稠度,降低肺动脉高压,增加心输出量,提高临床疗效。

关 键 词:肺原性心脏病  心力衰竭  低分子肝素
文章编号:1004-5775(2007)07-0502-02
修稿时间:2007-04-07

Curative Effect on Heart Failure Treated with Low Molecular Heparin in Pneumocardial Disease
ZHANG Zuo-qing,LIU Bao-zhen.Curative Effect on Heart Failure Treated with Low Molecular Heparin in Pneumocardial Disease[J].Heilongjiang Medical Journal,2007,31(7):502-503.
Authors:ZHANG Zuo-qing  LIU Bao-zhen
Institution:ZHANG Zuo- qing, LIU Bao - zhen The Shijingshan Hospital of Beijing City, Beijing 100043, China )
Abstract:Objective To discuss the curative effect on heart failure treated with low molecular heparin (LMH) in pneumocardiac disease. Methods The two groups were treated with routine method and routine method compounding LMH for 7 days. The curative effect and side effect were observed. Results The curative effect was better in test group than that in control group without side effect. Conclusion This method might decrease blood viscosity, pulmonary artery pressure and increase cardiac out put so that to improve clinical curative effect.
Keywords:Phemnocardial  Heart failure  low molecular heparin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号